Product Name: CHRNA9 Antibody
Species Reactivity: Dog, Human
Tested Applications: ELISA, WB
Applications: CHRNA9 antibody can be used for detection of CHRNA9 by ELISA at 1:312500. CHRNA9 antibody can be used for detection of CHRNA9 by western blot at 0.0625 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 – 100,000.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 55 kDa
Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human CHRNA9.
Host Species: Rabbit
Purification: Antibody is purified by peptide affinity chromatography method.
Physical State: Lyophilized
CAS NO.: 1374639-79-8
Product: LEE011 (succinate hydrate)
Buffer: Antibody is lyophilized in PBS buffer with 2% sucrose. Add 50 μL of distilled water. Final antibody concentration is 1 mg/mL.
Concentration: 1 mg/ml
Storage Conditions: For short periods of storage (days) store at 4˚C. For longer periods of storage, store CHRNA9 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: CHRNA9, NACHRA9, HSA243342
Accession NO.: NP_060051
Protein Ino: 70995130
Official Symbol: CHRNA9
Geneid: 55584
Background: CHRNA9 is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor superfamily. CHRNA9 is a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. It is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea.This gene is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor gene superfamily. It encodes a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. This protein is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea. The protein is additionally expressed in keratinocytes, the pituitary gland, B-cells and T-cells.
PubMed ID:http://aac.asm.org/content/36/2/408.abstract
